Aug 11, 2026 08:00AM
Jun 18, 2026 08:00AM
Jun 8, 2026 08:00AM
Jun 8, 2026 08:00AM
May 27, 2026 08:00AM
May 12, 2026 07:35AM
May 12, 2026 07:30AM Coya Therapeutics receives FDA fast track designation for ALS treatment
May 12, 2026 07:30AM
Apr 9, 2026 08:01AM
Apr 9, 2026 08:00AM
Apr 2, 2026 08:01AM
Apr 2, 2026 08:00AM
Mar 24, 2026 08:01AM
Mar 24, 2026 08:00AM ReAlta Life Sciences Appoints Howard Berman, Ph.D., as CEO and Kia Motesharei, Ph.D., as President and COO
Mar 18, 2026 08:00AM
Mar 18, 2026 08:00AM
Mar 16, 2026 08:00AM
Feb 10, 2026 08:00AM
Jan 30, 2026 08:00AM
Jan 30, 2026 08:00AM
Jan 20, 2026 08:04AM Coya Therapeutics CEO outlines 2026 priorities in stockholder letter
Jan 20, 2026 08:00AM
Jan 8, 2026 08:02AM
Jan 8, 2026 08:00AM
Jan 5, 2026 08:03AM
Jan 5, 2026 08:00AM
Dec 23, 2025 08:01AM
Dec 23, 2025 08:00AM Coya Therapeutics Receives Clinical Trial Application (CTA) Acceptance from Health Canada to Proceed with the COYA 302 ALSTARS Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Dec 9, 2025 08:00AM
Nov 25, 2025 08:00AM
Nov 12, 2025 08:00AM
Oct 27, 2025 04:01PM
Oct 27, 2025 04:01PM
Oct 24, 2025 06:30AM
Oct 24, 2025 06:30AM Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock
Oct 23, 2025 04:31PM
Oct 23, 2025 04:31PM
Sep 22, 2025 08:01AM
Sep 22, 2025 08:00AM
Sep 4, 2025 08:03AM
Sep 4, 2025 08:00AM
Sep 3, 2025 11:50AM PRISM MarketView Features Exclusive Q&A with Coya Therapeutics CEO Arun Swaminathan on Targeting Neurodegenerative Diseases Through Treg Therapies
Aug 25, 2025 08:00AM
Aug 25, 2025 06:42AM
Aug 25, 2025 05:22AM
Aug 12, 2025 08:00AM
Jul 24, 2025 08:15AM
Jul 24, 2025 08:15AM
Jul 22, 2025 08:15AM Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025
Jun 18, 2025 08:15AM

328,603 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All